Nature Holdings Co., Ltd.

Nature Holdings Co., Ltd.

KKRX:298540
6,380.00
KRW
-70.00
(-1.09%)
-203.75EPS
85.90BMarket Cap
Nov 12Next Earn
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
91,525.35
16,705.04
23,075.96
11,011.55
25,460
34,226.9
37,455
35,249.91
33,004.35
31,806.01
Basic EPS, GAAP
-1,937.5
1,019
1,583.5
1,439.5
4,009
4,717
3,377
1,118
471
-7.08
Free Cash Flow per Basic Share
3,307.26
1,731.44
59.15
-775.11
-3,198.2
783.52
986.24
2,438.84
1,312.04
2,258.28
Dividend per Share
- -
- -
- -
- -
199.99
199.99
397.32
425.6
522.26
- -
Book Value per Share
178.87
1,092.92
5,108.4
11,233.22
15,132
19,725.22
22,367.63
23,497.53
23,277.91
22,831.64
Tangible Book Value per Share
166.23
1,064.71
5,031.25
11,150.91
14,996.57
14,244.72
16,917.75
17,918.22
17,759.36
17,331.19
Basic Weighted Avg Shares
1
8
10
27
15
15
15
15
14
14
Sales/Revenue/Turnover
68,978
141,194
235,344
293,214
370,323
497,852
548,444
516,897
477,522
460,323
Operating Margin (%)
6.79
14.34
16.92
18.58
18.6
18.23
12.21
5.82
1.46
-1.06
Depreciation Expense
414
905
3,258
5,136
7,054
10,720
17,797
26,770
30,374
30,376
Net Income, GAAP
-1,460
8,613
16,150
38,331
58,312
68,612
49,449
16,394
6,815
-102
Effective Tax Rate (%)
- -
31.3
35.28
28.9
19.17
21.49
22.65
27.38
80.87
157.65
Profit Margin (%)
-2.12
6.1
6.86
13.07
15.75
13.78
9.02
3.17
1.43
-0.02
Working Capital
8,185
18,982
60,206
113,321
83,708
23,430
46,852
52,493
5,212
-7,142
LT Debt
560
5,403
7,021
34,767
40,794
13,169
15,801
25,880
9,685
8,931
Total Equity
2,641
16,137
75,443
163,389
220,090
319,507
369,288
399,624
392,722
387,493
Return on Invested Capital (%)
- -
65.26
41.24
24.44
20.36
17.68
10.11
3.81
0.22
0.48
Return on Capital (%)
- -
52.44
30.66
26.89
22.92
18.06
10.5
3.64
2.48
-0.08
Return on Common Equity (%)
- -
91.73
35.28
32.1
30.41
27.07
16.06
4.91
2.02
-0.03

Capital Structure

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
179,808
172,694
172,968
LT Borrowings
800
640
480
LT Finance Leases
8,885
9,290
8,451
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
14
14
14
Market Capitalization
127,770
107,054
85,904

Working Capital

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
259,286
250,899
230,560
Cash, Cash Equivalents & STI
70,071
72,984
69,058
Accounts Receivable, Net
36,567
- -
- -
Inventories
143,492
142,612
128,220
Total Current Liabilities
254,073
254,642
237,702
Payables & Accruals
- -
- -
- -
ST Debt
179,808
172,694
172,968
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
20.39%
-1.73%
Free Cash Flow
- -
25.66%
-46.92%
Net Income, GAAP
- -
-16.68%
-58.43%
Sales/Revenue/Turnover
- -
11.51%
-7.62%
Total Cash Common Dividend
- -
- -
21.08%

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
127,210
111,231
96,189
182,268
516,897
2025
128,794
96,753
93,370
158,604
477,522
2026
112,789
95,559
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
415
410
-492
794.54
1,118
2025
649
-216
-538.16
579.31
471
2026
31.48
-80
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
425.6
2025
- -
- -
- -
- -
522.26
2026
- -
- -
- -
- -
- -

Company Description

CEO
Young-Jun Park
Full Time Employees
347
Sector
Consumer non-durables
Industry
Apparel/Footwear
Address
10 Saechang-ro 44-gil Seoul SL South Korea 04366
IPO Date
Jul 27, 2020
Business
The Nature Holdings Co., Ltd. is a South Korea-based company primarily engaged in the manufacture and sale of health functional foods and beverages. Its core product portfolio includes dietary supplements, functional drinks, probiotics, and various natural health products under multiple brand names. The company serves the health and wellness market with offerings designed to enhance nutrition and promote well-being. Founded in 2002 and headquartered in Seoul, South Korea, The Nature Holdings operates both domestically and in select international markets. The company focuses on developing and commercializing scientifically backed health products, leveraging natural ingredients and advanced biotechnology. Its business segments include research and development of functional health products, manufacturing, marketing, and distribution. In the last 1-2 years, The Nature Holdings has pursued strategic expansions and innovation in product lines, including recent launches of new probiotic strains and functional beverages to address emerging consumer health trends. There have been partnerships formed with biotechnology firms and investments in research to strengthen its product efficacy and diversify its portfolio. The company continues to enhance its brand presence through these collaborations and expanded distribution channels. The Nature Holdings targets health-conscious consumers, including individuals seeking preventive health, digestive health, and immune support solutions. The company’s subsidiaries focus on specialty areas within the health functional foods industry, contributing to a comprehensive product offering. This profile reflects The Nature Holdings as an established player in the health functional foods sector with ongoing initiatives to innovate and grow through strategic partnerships, advanced research, and market expansion.